Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Actavis Inc       US9426831031

SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
Latest news on ACTAVIS INC
04/21 Generic drugmaker Teva makes $40 billion offer for rival Mylan
04/21DJTeva Offers to Buy Mylan for $40 Billion
04/21DJTeva Offers to Buy Mylan for $40 Billion -- 5th Update
04/20 ACTAVIS : Announces Retirement of Charles M. Mayr
04/20 ACTAVIS : Announces FDA Approval of Expanded Label for BOTOX® (Onabotulinumtoxin..
04/20 ACTAVIS : Announces Retirement of Charles M. Mayr
04/16 ACTAVIS : to Host First Quarter 2015 Earnings Conference Call and Webcast
04/13DJIBM Positions Itself as Large Broker of Health Data -- 2nd Update
04/13 ACTAVIS : No apologies for seeking Alzheimer's drug profits
04/13DJIBM Positions Itself as Large Broker of Health Data
04/13 ACTAVIS : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
04/08 Generic drugmaker Mylan offers $29 billion for Perrigo
04/08DJMylan Bids $205 a Share for Generic-Drug Maker Perrigo -- 5th Update
04/08 ACTAVIS : Amneal Signs Deal to Acquire the Generic Business of Actavis Australia
04/08DJMylan Bids for Generic Drug Maker Perrigo
04/08 ACTAVIS : Rhythm Initiates Phase 2b Clinical Trial of Relamorelin for Diabetic G..
04/08 ACTAVIS : Rhythm : Initiates Phase 2b Clinical Trial of Relamorelin for Diabetic..
04/06 ACTAVIS : Testosterone Lawsuit News: MDL Case Count Totals 1358
04/05 ACTAVIS : Amneal Plans to Acquire the Generic Business of Actavis Australia
04/03DJActavis Seeking FDA Approval to Market Generic Version of Gilead Drug -- Upda..
04/03DJActavis Seeks OK for Generic Version of Gilead Drug
04/03DJActavis Seeking FDA Approval to Market Generic Version of Gilead Drug
04/03 ACTAVIS : Confirms Generic Letairis® Patent Challenge
04/02 ACTAVIS : Amneal Plans to Acquire the Generic Business of Actavis Australia
04/02 PARATEK PHARMACEUTICALS : Reports Full Year 2014 Financial and Operating Results
03/31 ACTAVIS : Businesses to save €50 million through cheaper water, electricity bil..
03/31 ACTAVIS : to save three quarters of a million in energy bills
03/31 ACTAVIS : selling Australian generic drug unit to Amneal
03/31 ACTAVIS : Amneal Pharma to Acquire Generic Business of Actavis Australia
03/30 ACTAVIS : Amneal Signs Deal to Acquire the Generic Business of Actavis Australia
03/27 ACTAVIS : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
03/26 ACTAVIS : Completes Allergan Acquisition
03/26 ACTAVIS : Change in the relative benefit of bonds
03/26 ACTAVIS : Change in the relative benefit of bonds
03/26 ACTAVIS : Change in the relative benefit of bonds
03/26 ACTAVIS : Change in the relative benefit of bonds
03/25DJInvestors Scoop Up Companies' Bonds
03/25 ACTAVIS : Receives FDA Approval for VIIBRYD® vilazodone HCl 20mg Once Daily as a..
03/25 DAVID PYOTT : Actavis Announces Michael R. Gallagher and Peter J. McDonnell to J..
03/25 ACTAVIS : European Commission Clears Actavis' Pending Acquisition of Allergan
03/23 TREVENA : Posts Full Year 2014 Financial Results
03/22 ACTAVIS : and Allergan Shareholders OK Proposals for Actavis' Acquisition of All..
03/20 American Airlines Group Tapped for the S&P 500
03/20 ACTAVIS : Finalizes Allergan Acquisition
03/19 ALLERGAN : European Commission OKs Actavis' Pending Acquisition of Allergan
03/18 TREVENA : completes interim analysis and announces plans for ongoing Phase 2b BL..
03/18 ACTAVIS : Receives FDA Approval of SAPHRIS® for Pediatric Patients age 10-17 for..
03/18 ACTAVIS : Entry into a Material Definitive Agreement, Completion of Acquisition ..
03/17 TREVENA : Reports Full Year 2014 Financial Results
03/17 DAVID PYOTT : Actavis says Allergan's Pyott won't join new company's board
03/16 ALLERGAN : Actavis Announces Michael R. Gallagher and Peter J. McDonnell to Join..
03/16 American Airlines Group To Replace Allergan In S&P 500
03/16DJValeant Raises Offer To $173/Share In New Deal for Salix--6th Update
03/16DJValeant Raises Offer To $173/Share In New Deal for Salix--6th Update
03/16 American Airlines to join S&P 500
03/16 ACTAVIS : Other Events, Financial Statements and Exhibits (form 8-K)
03/16 ACTAVIS : Receives FDA Approval for VIIBRYD® (vilazodone HCl) 20mg Once Daily as..
03/16DJValeant Raises Offer To $173/Share In New Deal for Salix--6th Update
03/16DJValeant Raises Offer To $173/Share In New Deal for Salix--6th Update
03/16DJValeant Raises Offer To $173/Share In New Deal for Salix--5th Update
03/16DJValeant Raises Offer To $173/Share In New Deal for Salix--4th Update
03/16DJValeant Raises Offer To $173/Share In New Deal for Salix--3rd Update
03/16DJValeant Raises Offer To $173/Share In New Deal for Salix--2nd Update
03/16 ALLERGAN : Actavis and Allergan Receive Shareholder Approval of Proposals Relate..
03/15 ACTAVIS : to sponsor 2015 LifeCycle Challenge
03/15 TREVENA : Reports on Phase 2b BLAST-AHF Trial of TRV027
03/13 ACTAVIS : Entry into a Material Definitive Agreement, Creation of a Direct Finan..
03/13 ALLERGAN : Actavis and Allergan Shareholders OK Proposals Related to Planned Acq..
03/13 ALLERGAN : Actavis and Allergan Shareholders OK Proposals for Actavis' Acquisiti..
03/13 ALLERGAN : Actavis and Allergan Shareholders OK Proposals Related to Actavis' Pl..
03/13 ACTAVIS : Receives FDA Approval of SAPHRIS® for Pediatric Patients (age 10-17) f..
03/12 ACTAVIS : Confirms Appeals Court Grants Injunction Pending Appeal Related to Gen..
03/12 ACTAVIS : Entry into a Material Definitive Agreement, Other Events, Financial St..
03/12 ACTAVIS : Announces Closing of Public Offering of Senior Notes in Connection wit..
03/12 TREVENA : Updates on Phase 2b BLAST-AHF Trial of TRV027
Prev.1   2  3  4  5  6  7  8  9  10Next
Advertisement
Income Statement Evolution
More Financials